Capital expenditure · 2020–2025

Starling Oncology capital expenditure

$3.2M−15.5% · FY2025

Starling Oncology (STLN) reported $3.2M in capital expenditure for fiscal 2025, −15.5% year on year.

$1.2M2020$2.8M2021$5.5M2022$4.6M2023$3.8M2024$3.2M2025
Starling Oncology — Capital expenditure, 2020–2025
Fiscal yearCapital expenditureChangeFiling
FY20252025-12-31$3.2M−15.5%Open →
FY20242024-12-31$3.8M−17.0%Open →
FY20232023-12-31$4.6M−17.4%Open →
FY20222022-12-31$5.5M+94.2%Open →
FY20212021-12-31$2.8M+138.4%Open →
FY20202020-12-31$1.2M—Open →

Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2020–2025 compound annual growth +21.8%

Capital expenditure at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Starling Oncology capital expenditure |url=https://companiesranked.com/en/company/starling-oncology/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Starling Oncology capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/starling-oncology/capital-expenditure

BibTeX

@misc{companiesranked-en-company-starling-oncology-capital-expenditure-2026,
  author       = {{CompaniesRanked}},
  title        = {{Starling Oncology capital expenditure}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/starling-oncology/capital-expenditure}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001799191-26-000007 · March 12, 2026

{{cite web |title=Starling Oncology capital expenditure — 10-K (0001799191-26-000007) |url=https://www.sec.gov/Archives/edgar/data/1799191/000179919126000007/toi-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-12}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Starling Oncology overview